See also this year's filing and all EDGAR filings for this company.
PDF Report 0001768446_2023_Eliem_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100060 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2': 2, '100070 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 12}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001768446, Eliem Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 134,393,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 599,000 |
4 | LiabilitiesCurrent | 6,097,000 |
5 | LiabilitiesNoncurrent | 180,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 18,921,000 |
9 | ResearchAndDevelopmentExpense | 26,214,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -109,000 |
13 | remainder_ComprehensiveNetIncome | -235,000 |
yvar | yval | |
---|---|---|
0 | Assets | 134,992,000 |
1 | Liabilities | 6,277,000 |
2 | Expenses | 45,135,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 128,715,000 |
5 | NetIncome | -45,244,000 |
6 | ComprehensiveNetIncome | -45,361,500 |
7 | BaseVar | 93,374,000 |
8 | EconomicCapitalRatio | 2.49 |